Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole versus itraconazole prophylaxis after allogeneic HSCT
2005-002800-40Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of voriconazole and itraconazole in invasive mycoses (2 arms), sponsored by Pfizer. Primary endpoint: Success at Day 180. Started Nov 2005; status: completed.
02
Drugs
voriconazoleitraconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on 2005-002800-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002800-40.